Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Blood (2012) Vol. 120, Iss. 15, pp. 3080-3088
Open Access | Times Cited: 287

Showing 1-25 of 287 citing articles:

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1676
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Journal of Clinical Oncology (2013) Vol. 31, Iss. 19, pp. 2428-2436
Open Access | Times Cited: 505
Regulation of splicing by SR proteins and SR protein-specific kinases
Zhihong Zhou, Xiang‐Dong Fu
Chromosoma (2013) Vol. 122, Iss. 3, pp. 191-207
Open Access | Times Cited: 422
Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Laura M. Urbanski, Nathan K. Leclair, Olga Anczuków
Wiley Interdisciplinary Reviews - RNA (2018) Vol. 9, Iss. 4
Open Access | Times Cited: 327
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena, Anna Gallí, Esperanza Such, et al.
Blood (2016) Vol. 128, Iss. 10, pp. 1408-1417
Open Access | Times Cited: 300
Genetics of MDS
Seishi Ogawa
Blood (2019) Vol. 133, Iss. 10, pp. 1049-1059
Open Access | Times Cited: 299
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
Brian Kwok, Jeff Hall, John S. Witte, et al.
Blood (2015) Vol. 126, Iss. 21, pp. 2355-2361
Open Access | Times Cited: 296
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
Esperanza Such, Ulrich Germing, Luca Malcovati, et al.
Blood (2013) Vol. 121, Iss. 15, pp. 3005-3015
Open Access | Times Cited: 288
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
Mrinal M. Patnaik, Raphaël Itzykson, Terra L. Lasho, et al.
Leukemia (2014) Vol. 28, Iss. 11, pp. 2206-2212
Closed Access | Times Cited: 257
Clonal architecture of chronic myelomonocytic leukemias
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Blood (2013) Vol. 121, Iss. 12, pp. 2186-2198
Open Access | Times Cited: 254
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
Blood (2013) Vol. 122, Iss. 14, pp. 2460-2466
Open Access | Times Cited: 244
Connections between TET proteins and aberrant DNA modification in cancer
Yun Huang, Anjana Rao
Trends in Genetics (2014) Vol. 30, Iss. 10, pp. 464-474
Open Access | Times Cited: 238
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, et al.
Blood (2014) Vol. 124, Iss. 9, pp. 1513-1521
Open Access | Times Cited: 235
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Vikas Madan, Deepika Kanojia, Jia Li, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 220
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis
Mohamad Jawhar, Juliana Schwaab, Susanne Schnittger, et al.
Leukemia (2015) Vol. 30, Iss. 1, pp. 136-143
Closed Access | Times Cited: 202
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang, Robert P. Hasserjian, Patricia S. Fox, et al.
Blood (2014) Vol. 123, Iss. 17, pp. 2645-2651
Open Access | Times Cited: 201
SON and SRRM2 are essential for nuclear speckle formation
İbrahim Ilik, Michał Małszycki, Anna Katharina Lübke, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 195
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations
Stanley Chun-Wei Lee, Khrystyna North, Eun Hee Kim, et al.
Cancer Cell (2018) Vol. 34, Iss. 2, pp. 225-241.e8
Open Access | Times Cited: 192
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
Laura Palomo, Manja Meggendorfer, Stephan Hütter, et al.
Blood (2020) Vol. 136, Iss. 16, pp. 1851-1862
Open Access | Times Cited: 151
Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2022) Vol. 97, Iss. 3, pp. 352-372
Closed Access | Times Cited: 72
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1142-1165
Open Access | Times Cited: 24
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
Manja Meggendorfer, Ulrike Bacher, Tamara Alpermann, et al.
Leukemia (2013) Vol. 27, Iss. 9, pp. 1852-1860
Closed Access | Times Cited: 177
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Michael R. Savona, Luca Malcovati, Rami S. Komrokji, et al.
Blood (2015) Vol. 125, Iss. 12, pp. 1857-1865
Open Access | Times Cited: 172
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia
Kristen Meldi, Tingting Qin, Francesca Buchi, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 5, pp. 1857-1872
Open Access | Times Cited: 162
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
Bartlomiej Przychodzen, Andrés Jerez, Kathryn M Guinta, et al.
Blood (2013) Vol. 122, Iss. 6, pp. 999-1006
Open Access | Times Cited: 156
Page 1 - Next Page

Scroll to top